Shamala Mohanasundaram, MD
Family Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Offices
- 2
Offices
2 locations · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mohanasundaram’s office at (408) 866-4070 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A112811 · Current
Licensed to practise in California · since 2010 · expires 2027-12-31 · Kuvempu University, J.J.M. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$82,478
Medicare paid this office $82,478 for 238 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 160 | $25,157 | $157 |
| Return visit (30+ min) | 137 | $19,798 | $97 |
| Short return visit (20+ min) | 122 | $16,299 | $74 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 21 | $4,171 | $199 |
| Influenza vaccine, inactivated | 38 | $3,109 | $82 |
See all 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 160 | $25,157 | $157 |
| Return visit (30+ min) | 137 | $19,798 | $97 |
| Short return visit (20+ min) | 122 | $16,299 | $74 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 21 | $4,171 | $199 |
| Influenza vaccine, inactivated | 38 | $3,109 | $82 |
| Administration of influenza virus vaccine | 39 | $1,479 | $38 |
| New patient visit (30+ min) | 11 | $1,069 | $97 |
Who their Medicare patients are
238 Original Medicare patients in 2024. Average age 73 · Women 72% · Health risk score 0.63. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 56% · Coronary heart disease 17% · Diabetes 13% · Chronic kidney disease 10% · Cancer 8% · Atrial fibrillation 8% · Depression 7% · Heart failure 6% · COPD 6%.
The office billed $317,665, Medicare allowed $106,190 and paid $82,478; for 898 services of 38 kinds; $3,471 of it was for drugs given in the office and $79,007 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 238 | 898 | 73 | 0.63 | $317,665 | $82,478 |
| 2023 | 198 | 620 | 73 | 0.59 | $244,314 | $60,715 |
| 2022 | 178 | 548 | 72 | 0.63 | $219,464 | $58,389 |
| 2021 | 182 | 626 | 72 | 0.63 | $239,141 | $57,264 |
| 2020 | 167 | 570 | 72 | 0.77 | $127,074 | $48,527 |
| 2019 | 140 | 506 | 71 | 0.77 | $63,776 | $42,042 |
| 2018 | 126 | 424 | 72 | 0.85 | $48,677 | $34,308 |
| 2017 | 108 | 381 | 72 | 0.91 | $42,308 | $28,384 |
| 2016 | 110 | 412 | 72 | 1.02 | $43,132 | $29,778 |
| 2015 | 108 | 376 | 73 | 1.08 | $40,980 | $27,259 |
| 2014 | 114 | 397 | 72 | 0.99 | $45,949 | $29,202 |
| 2013 | 94 | 313 | 73 | 1.14 | $40,783 | $23,883 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 144 | $22,450 | $156 |
| Return visit (30+ min) | 113 | $15,733 | $95 |
| Short return visit (20+ min) | 85 | $7,938 | $69 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $3,956 | $283 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 35 | $2,610 | $75 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $2,172 | $197 |
| Administration of influenza virus vaccine | 35 | $1,139 | $33 |
| Administration of pneumococcal vaccine | 15 | $484 | $32 |
2022: 6 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 138 | $21,851 | $158 |
| Return visit (30+ min) | 90 | $14,905 | $96 |
| Short return visit (20+ min) | 90 | $8,052 | $67 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 16 | $4,436 | $277 |
| Pneumococcal vaccine, 23-valent | 15 | $1,979 | $132 |
| Administration of pneumococcal vaccine | 32 | $1,041 | $33 |
2021: 10 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 119 | $19,183 | $161 |
| Return visit (30+ min) | 88 | $14,321 | $106 |
| Short return visit (20+ min) | 87 | $8,633 | $67 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 13 | $2,638 | $203 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 12 | $2,441 | $203 |
| Influenza vaccine, inactivated | 35 | $2,056 | $59 |
| Pneumococcal vaccine, 23-valent | 13 | $1,381 | $106 |
| Administration of influenza virus vaccine | 38 | $821 | $22 |
| Administration of pneumococcal vaccine | 22 | $473 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $221 | $15 |
2020: 9 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 103 | $14,600 | $142 |
| Return visit (30+ min) | 70 | $9,409 | $91 |
| Short return visit (20+ min) | 89 | $8,161 | $58 |
| Pneumococcal vaccine, 13-valent | 18 | $4,083 | $227 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $2,208 | $201 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 35 | $2,135 | $61 |
| Pneumococcal vaccine, 23-valent | 11 | $1,319 | $120 |
| Administration of influenza virus vaccine | 36 | $753 | $21 |
| Administration of pneumococcal vaccine | 29 | $606 | $21 |
2019: 11 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 90 | $12,526 | $139 |
| Return visit (30+ min) | 78 | $11,141 | $84 |
| Short return visit (20+ min) | 64 | $5,066 | $58 |
| Pneumococcal vaccine, 13-valent | 11 | $2,301 | $209 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $2,232 | $203 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $2,156 | $196 |
| Influenza vaccine, inactivated | 28 | $1,378 | $49 |
| New patient visit (30+ min) | 14 | $1,252 | $89 |
| Pneumococcal vaccine, 23-valent | 12 | $1,162 | $97 |
| Administration of influenza virus vaccine | 29 | $595 | $21 |
| Administration of pneumococcal vaccine | 23 | $472 | $21 |
2018: 8 services
| Return visit (30+ min) | 66 | $9,681 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 63 | $8,843 | $140 |
| Short return visit (20+ min) | 59 | $4,417 | $51 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $2,243 | $204 |
| Pneumococcal vaccine, 13-valent | 11 | $2,174 | $198 |
| Influenza vaccine, inactivated | 26 | $1,351 | $50 |
| Administration of influenza virus vaccine | 26 | $695 | $26 |
| Administration of pneumococcal vaccine | 20 | $515 | $26 |
2017: 5 services
| Return visit (30+ min) | 62 | $8,536 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 56 | $7,450 | $133 |
| Short return visit (20+ min) | 53 | $4,674 | $54 |
| Influenza vaccine, inactivated | 23 | $1,132 | $49 |
| Administration of influenza virus vaccine | 24 | $774 | $32 |
2016: 7 services
| Return visit (30+ min) | 59 | $7,653 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $6,883 | $138 |
| Short return visit (20+ min) | 59 | $6,752 | $58 |
| Influenza vaccine split virus, preservative free | 26 | $1,007 | $39 |
| Administration of influenza virus vaccine | 27 | $855 | $32 |
| New patient visit (30+ min) | 11 | $754 | $69 |
| Short return visit | 11 | $416 | $30 |
2015: 7 services
| Return visit (30+ min) | 63 | $8,887 | $86 |
| Short return visit (20+ min) | 57 | $5,983 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $5,616 | $137 |
| New patient visit (30+ min) | 17 | $1,501 | $88 |
| Short return visit | 13 | $874 | $40 |
| Influenza vaccine split virus, preservative free | 17 | $605 | $36 |
| Administration of influenza virus vaccine | 18 | $572 | $32 |
2014: 7 services
| Return visit (30+ min) | 57 | $7,876 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 38 | $5,010 | $132 |
| Short return visit (20+ min) | 50 | $4,891 | $61 |
| New patient visit (30+ min) | 33 | $2,535 | $77 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 11 | $1,912 | $147 |
| Administration of influenza virus vaccine | 30 | $996 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 26 | $392 | $15 |
2013: 7 services
| Return visit (30+ min) | 37 | $5,081 | $88 |
| Short return visit (20+ min) | 38 | $4,793 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,200 | $133 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 17 | $2,531 | $141 |
| New patient visit (30+ min) | 23 | $2,018 | $88 |
| Administration of influenza virus vaccine | 19 | $636 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 14 | $157 | $11 |
Drugs they prescribed that Part D paid
$128,987
Pharmacies billed $128,987 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (51 of 2,329) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
2,104 generic and 208 brand-name prescriptions · $128,987 in drug cost · 62 antibiotic prescriptions to 32 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Januvia | 29 | $27,690 | $955 |
| Eliquis | 11 | $11,236 | $1,021 |
| Paxlovid | 14 | $5,717 | $408 |
| Synthroid | 26 | $3,045 | $117 |
| Levothyroxine | 172 | $1,930 | $11 |
See all 55 drugs
| Januvia | 29 | $27,690 | $955 |
| Eliquis | 11 | $11,236 | $1,021 |
| Paxlovid | 14 | $5,717 | $408 |
| Synthroid | 26 | $3,045 | $117 |
| Levothyroxine | 172 | $1,930 | $11 |
| Liothyronine | 33 | $1,695 | $51 |
| Atorvastatin | 184 | $1,321 | $7 |
| Rosuvastatin | 83 | $1,246 | $15 |
| Zolpidem | 60 | $1,031 | $17 |
| Bupropion Xl | 26 | $988 | $38 |
| Gabapentin | 53 | $955 | $18 |
| Estradiol | 29 | $935 | $32 |
| Celecoxib | 22 | $802 | $36 |
| Simvastatin | 32 | $674 | $21 |
| Hydrocodone-Acetaminophen | 21 | $653 | $31 |
| Telmisartan | 18 | $593 | $33 |
| Amlodipine Besylate | 85 | $574 | $7 |
| Losartan | 83 | $548 | $7 |
| Amitriptyline | 11 | $539 | $49 |
| Albuterol Sulfate Hfa | 33 | $530 | $16 |
| Lisinopril | 68 | $529 | $8 |
| Azelastine | 16 | $511 | $32 |
| Escitalopram | 24 | $501 | $21 |
| Metoprolol | 38 | $477 | $13 |
| Pantoprazole | 30 | $471 | $16 |
| Ezetimibe | 13 | $427 | $33 |
| Duloxetine | 12 | $409 | $34 |
| Lorazepam | 27 | $388 | $14 |
| Alprazolam | 50 | $369 | $7 |
| Sertraline | 26 | $349 | $13 |
| Alendronate | 29 | $341 | $12 |
| Fenofibrate | 16 | $328 | $21 |
| Losartan-Hydrochlorothiazide | 25 | $328 | $13 |
| Clonazepam | 12 | $323 | $27 |
| Acyclovir | 14 | $306 | $22 |
| Oxycodone | 12 | $300 | $25 |
| Cyclobenzaprine | 11 | $297 | $27 |
| Dicyclomine | 17 | $291 | $17 |
| Metoprolol | 11 | $226 | $21 |
| Metformin | 33 | $202 | $6 |
| Paroxetine | 25 | $201 | $8 |
| Omeprazole | 16 | $201 | $13 |
| Trazodone | 20 | $163 | $8 |
| Tamsulosin | 17 | $156 | $9 |
| Ibuprofen | 12 | $146 | $12 |
| Triamcinolone Acetonide | 17 | $126 | $7 |
| Prednisone | 33 | $124 | $4 |
| Hydrochlorothiazide | 43 | $110 | $3 |
| Doxycycline Monohydrate | 11 | $106 | $10 |
| Pravastatin | 21 | $69 | $3 |
| Famciclovir | 11 | $61 | $6 |
| Azithromycin | 11 | $56 | $5 |
| Tizanidine | 13 | $36 | $3 |
| Benazepril | 14 | $27 | $2 |
| Irbesartan | 13 | $1 | $0 |
Year by year
| 2024 | 2,329 | 214 | 2% (51) | 9% | $128,987 |
| 2023 | 1,919 | 184 | 3% (57) | 9% | $114,891 |
| 2022 | 1,622 | 159 | 3% (49) | 10% | $107,688 |
| 2021 | 1,614 | 155 | 3% (54) | 12% | $119,295 |
| 2020 | 1,471 | 141 | 3% (44) | None | $92,882 |
| 2019 | 1,275 | 117 | 3% (37) | 14% | $90,648 |
| 2018 | 1,284 | 110 | 4% (46) | 13% | $78,290 |
| 2017 | 1,418 | 94 | 5% (65) | None | $63,306 |
| 2016 | 1,442 | 93 | 4% (63) | None | $69,966 |
| 2015 | 1,568 | 87 | 3% (44) | 17% | $74,376 |
| 2014 | 1,142 | 75 | 2% (26) | 17% | $73,655 |
| 2013 | 981 | 60 | 2% (18) | 21% | $86,339 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 51 drugs
| Januvia | 23 | $19,297 | $839 |
| Synthroid | 19 | $2,321 | $122 |
| Gabapentin | 48 | $1,789 | $37 |
| Levothyroxine | 149 | $1,789 | $12 |
| Rosuvastatin | 73 | $1,606 | $22 |
| Liothyronine | 33 | $1,432 | $43 |
| Telmisartan | 12 | $1,412 | $118 |
| Estradiol | 19 | $1,405 | $74 |
| Celecoxib | 16 | $1,396 | $87 |
| Atorvastatin | 141 | $1,340 | $10 |
| Amitriptyline | 11 | $789 | $72 |
| Bupropion Xl | 31 | $774 | $25 |
| Nifedipine Er | 11 | $701 | $64 |
| Hydrocodone-Acetaminophen | 16 | $649 | $41 |
| Metoprolol | 33 | $602 | $18 |
| Albuterol Sulfate Hfa | 19 | $593 | $31 |
| Escitalopram | 32 | $591 | $18 |
| Zolpidem | 36 | $555 | $15 |
| Azelastine | 18 | $551 | $31 |
| Dicyclomine | 24 | $519 | $22 |
| Ezetimibe | 11 | $509 | $46 |
| Lisinopril | 57 | $507 | $9 |
| Amlodipine Besylate | 60 | $482 | $8 |
| Losartan | 35 | $447 | $13 |
| Alprazolam | 43 | $382 | $9 |
| Metformin | 24 | $365 | $15 |
| Alendronate | 24 | $362 | $15 |
| Acyclovir | 13 | $352 | $27 |
| Pantoprazole | 27 | $349 | $13 |
| Losartan-Hydrochlorothiazide | 14 | $328 | $23 |
| Omeprazole | 19 | $318 | $17 |
| Simvastatin | 32 | $298 | $9 |
| Sertraline | 24 | $282 | $12 |
| Lorazepam | 27 | $279 | $10 |
| Carisoprodol | 16 | $274 | $17 |
| Oxycodone | 12 | $272 | $23 |
| Eszopiclone | 11 | $206 | $19 |
| Paroxetine | 22 | $204 | $9 |
| Trazodone | 19 | $182 | $10 |
| Paxlovid (Eua) | 18 | $182 | $10 |
| Montelukast | 13 | $177 | $14 |
| Hydrochlorothiazide | 26 | $146 | $6 |
| Metoprolol | 11 | $144 | $13 |
| Prednisone | 23 | $132 | $6 |
| Triamcinolone Acetonide | 13 | $113 | $9 |
| Benazepril | 12 | $108 | $9 |
| Fluticasone Propionate | 11 | $102 | $9 |
| Cyclobenzaprine | 11 | $84 | $8 |
| Pravastatin | 11 | $83 | $8 |
| Tramadol | 18 | $41 | $2 |
| Tizanidine | 12 | $25 | $2 |
2022: 41 drugs
| Januvia | 18 | $17,834 | $991 |
| Gabapentin | 54 | $2,974 | $55 |
| Levothyroxine | 130 | $2,634 | $20 |
| Synthroid | 17 | $1,837 | $108 |
| Celecoxib | 16 | $1,613 | $101 |
| Atorvastatin | 124 | $1,557 | $13 |
| Liothyronine | 22 | $1,528 | $69 |
| Telmisartan | 11 | $1,444 | $131 |
| Bupropion Xl | 28 | $956 | $34 |
| Rosuvastatin | 44 | $887 | $20 |
| Estradiol | 15 | $714 | $48 |
| Losartan-Hydrochlorothiazide | 18 | $700 | $39 |
| Metoprolol | 36 | $691 | $19 |
| Escitalopram | 39 | $623 | $16 |
| Sertraline | 24 | $566 | $24 |
| Albuterol Sulfate Hfa | 13 | $524 | $40 |
| Amitriptyline | 11 | $439 | $40 |
| Alprazolam | 43 | $418 | $10 |
| Allopurinol | 13 | $407 | $31 |
| Trazodone | 23 | $397 | $17 |
| Hydrocodone-Acetaminophen | 18 | $395 | $22 |
| Lisinopril | 50 | $384 | $8 |
| Zolpidem | 31 | $371 | $12 |
| Omeprazole | 22 | $365 | $17 |
| Montelukast | 14 | $346 | $25 |
| Amlodipine Besylate | 52 | $346 | $7 |
| Losartan | 27 | $311 | $12 |
| Pantoprazole | 11 | $255 | $23 |
| Quetiapine | 14 | $227 | $16 |
| Valsartan | 11 | $223 | $20 |
| Cyclobenzaprine | 12 | $218 | $18 |
| Alendronate | 12 | $198 | $17 |
| Simvastatin | 27 | $197 | $7 |
| Lorazepam | 25 | $186 | $7 |
| Metformin | 26 | $145 | $6 |
| Acyclovir | 12 | $140 | $12 |
| Paxlovid (Eua) | 12 | $116 | $10 |
| Clonazepam | 11 | $105 | $10 |
| Hydrochlorothiazide | 21 | $96 | $5 |
| Tramadol | 17 | $50 | $3 |
| Benazepril | 11 | $28 | $3 |
2021: 40 drugs
| Januvia | 18 | $15,654 | $870 |
| Levothyroxine | 130 | $3,010 | $23 |
| Liothyronine | 43 | $2,550 | $59 |
| Synthroid | 17 | $1,848 | $109 |
| Atorvastatin | 113 | $1,746 | $15 |
| Estradiol | 27 | $1,586 | $59 |
| Telmisartan | 12 | $1,208 | $101 |
| Gabapentin | 44 | $1,172 | $27 |
| Rosuvastatin | 29 | $1,102 | $38 |
| Bupropion Xl | 27 | $1,037 | $38 |
| Armour Thyroid | 11 | $1,014 | $92 |
| Alprazolam | 32 | $861 | $27 |
| Ezetimibe | 11 | $693 | $63 |
| Sertraline | 29 | $612 | $21 |
| Losartan-Hydrochlorothiazide | 13 | $574 | $44 |
| Metoprolol | 28 | $488 | $17 |
| Amitriptyline | 13 | $471 | $36 |
| Zolpidem | 53 | $445 | $8 |
| Escitalopram | 33 | $420 | $13 |
| Paroxetine | 14 | $382 | $27 |
| Allopurinol | 12 | $370 | $31 |
| Losartan | 24 | $369 | $15 |
| Amlodipine Besylate | 46 | $349 | $8 |
| Montelukast | 19 | $332 | $17 |
| Dextroamphetamine-Amphetamine | 13 | $324 | $25 |
| Lisinopril | 34 | $286 | $8 |
| Alendronate | 15 | $281 | $19 |
| Cyclobenzaprine | 17 | $280 | $16 |
| Hydrocodone-Acetaminophen | 18 | $273 | $15 |
| Lorazepam | 29 | $227 | $8 |
| Simvastatin | 33 | $216 | $7 |
| Meloxicam | 13 | $215 | $17 |
| Omeprazole | 18 | $180 | $10 |
| Metformin | 20 | $164 | $8 |
| Hydrochlorothiazide | 14 | $130 | $9 |
| Prednisone | 15 | $90 | $6 |
| Tramadol | 26 | $89 | $3 |
| Trazodone | 11 | $89 | $8 |
| Triamcinolone Acetonide | 11 | $69 | $6 |
| Benazepril | 13 | $49 | $4 |
2020: 35 drugs
| Januvia | 11 | $9,161 | $833 |
| Levothyroxine | 129 | $3,278 | $25 |
| Liothyronine | 46 | $2,146 | $47 |
| Pulmicort Flexhaler | 11 | $2,027 | $184 |
| Atorvastatin | 116 | $1,954 | $17 |
| Synthroid | 18 | $1,687 | $94 |
| Estradiol | 17 | $1,391 | $82 |
| Telmisartan | 11 | $1,256 | $114 |
| Celecoxib | 11 | $1,237 | $112 |
| Bupropion Xl | 25 | $1,145 | $46 |
| Losartan-Hydrochlorothiazide | 12 | $1,010 | $84 |
| Gabapentin | 37 | $990 | $27 |
| Albuterol Sulfate Hfa | 16 | $905 | $57 |
| Sertraline | 28 | $717 | $26 |
| Alprazolam | 33 | $558 | $17 |
| Zolpidem | 54 | $438 | $8 |
| Metoprolol | 19 | $416 | $22 |
| Allopurinol | 16 | $393 | $25 |
| Losartan | 25 | $388 | $16 |
| Montelukast | 21 | $320 | $15 |
| Simvastatin | 36 | $301 | $8 |
| Cyclobenzaprine | 14 | $300 | $21 |
| Escitalopram | 18 | $276 | $15 |
| Omeprazole | 18 | $257 | $14 |
| Fluticasone Propionate | 11 | $256 | $23 |
| Lisinopril | 34 | $247 | $7 |
| Lovastatin | 14 | $220 | $16 |
| Metformin | 21 | $214 | $10 |
| Amlodipine Besylate | 33 | $193 | $6 |
| Lorazepam | 23 | $184 | $8 |
| Alendronate | 12 | $152 | $13 |
| Prednisone | 26 | $98 | $4 |
| Hydrochlorothiazide | 17 | $90 | $5 |
| Tramadol | 18 | $81 | $4 |
| Paroxetine | 14 | $57 | $4 |
2019: 37 drugs
| Levothyroxine | 113 | $3,018 | $27 |
| Estradiol | 18 | $2,103 | $117 |
| Liothyronine | 34 | $1,973 | $58 |
| Atorvastatin | 85 | $1,915 | $23 |
| Armour Thyroid | 12 | $1,327 | $111 |
| Telmisartan | 11 | $1,196 | $109 |
| Celecoxib | 12 | $1,132 | $94 |
| Bupropion Xl | 26 | $970 | $37 |
| Gabapentin | 26 | $965 | $37 |
| Hydroxychloroquine Sulfate | 13 | $865 | $67 |
| Ventolin Hfa | 11 | $736 | $67 |
| Zolpidem | 33 | $523 | $16 |
| Metoprolol | 18 | $484 | $27 |
| Sulfamethoxazole-Trimethoprim | 12 | $454 | $38 |
| Sertraline | 27 | $447 | $17 |
| Escitalopram | 18 | $434 | $24 |
| Montelukast | 18 | $417 | $23 |
| Rizatriptan | 11 | $372 | $34 |
| Alprazolam | 16 | $363 | $23 |
| Hydrocodone-Acetaminophen | 16 | $356 | $22 |
| Allopurinol | 14 | $311 | $22 |
| Amlodipine Besylate | 38 | $288 | $8 |
| Simvastatin | 34 | $284 | $8 |
| Fluoxetine | 16 | $280 | $18 |
| Omeprazole | 15 | $264 | $18 |
| Lorazepam | 17 | $252 | $15 |
| Losartan-Hydrochlorothiazide | 11 | $241 | $22 |
| Fluticasone Propionate | 14 | $236 | $17 |
| Oxycodone-Acetaminophen | 11 | $211 | $19 |
| Lisinopril | 22 | $189 | $9 |
| Metformin | 19 | $188 | $10 |
| Hydrochlorothiazide | 23 | $183 | $8 |
| Lovastatin | 13 | $169 | $13 |
| Losartan | 15 | $141 | $9 |
| Prednisone | 34 | $139 | $4 |
| Triamcinolone Acetonide | 13 | $134 | $10 |
| Azithromycin | 14 | $103 | $7 |
2018: 32 drugs
| Levothyroxine | 104 | $2,783 | $27 |
| Estradiol | 22 | $2,568 | $117 |
| Bupropion Xl | 24 | $1,859 | $77 |
| Liothyronine | 36 | $1,809 | $50 |
| Atorvastatin | 68 | $1,678 | $25 |
| Celecoxib | 15 | $1,457 | $97 |
| Hydrocodone-Acetaminophen | 36 | $1,159 | $32 |
| Armour Thyroid | 16 | $985 | $62 |
| Gabapentin | 40 | $949 | $24 |
| Enalapril Maleate | 12 | $526 | $44 |
| Escitalopram | 19 | $512 | $27 |
| Zolpidem | 41 | $511 | $12 |
| Allopurinol | 16 | $392 | $24 |
| Venlafaxine Hcl Er | 13 | $364 | $28 |
| Montelukast | 15 | $338 | $23 |
| Omeprazole | 21 | $335 | $16 |
| Alprazolam | 17 | $330 | $19 |
| Fludrocortisone Acetate | 12 | $319 | $27 |
| Simvastatin | 35 | $294 | $8 |
| Trazodone | 20 | $281 | $14 |
| Lovastatin | 20 | $280 | $14 |
| Losartan-Hydrochlorothiazide | 11 | $257 | $23 |
| Hydrochlorothiazide | 33 | $213 | $6 |
| Triamcinolone Acetonide | 12 | $182 | $15 |
| Metformin | 19 | $180 | $9 |
| Sertraline | 24 | $167 | $7 |
| Amlodipine Besylate | 22 | $166 | $8 |
| Lorazepam | 15 | $159 | $11 |
| Losartan | 19 | $153 | $8 |
| Lisinopril | 22 | $145 | $7 |
| Prednisone | 11 | $82 | $7 |
| Metoprolol | 13 | $66 | $5 |
2017: 41 drugs
| Estrace | 14 | $4,283 | $306 |
| Savella | 12 | $3,819 | $318 |
| Advair Diskus | 11 | $3,220 | $293 |
| Levothyroxine | 134 | $3,137 | $23 |
| Premarin | 13 | $2,179 | $168 |
| Bupropion Xl | 36 | $1,346 | $37 |
| Celecoxib | 13 | $1,077 | $83 |
| Gabapentin | 62 | $895 | $14 |
| Liothyronine | 41 | $893 | $22 |
| Atorvastatin | 35 | $811 | $23 |
| Zolpidem | 37 | $723 | $20 |
| Enalapril Maleate | 13 | $594 | $46 |
| Oxybutynin Chloride Er | 12 | $583 | $49 |
| Escitalopram | 26 | $551 | $21 |
| Lorazepam | 37 | $481 | $13 |
| Oxycodone-Acetaminophen | 18 | $479 | $27 |
| Hydrocodone-Acetaminophen | 37 | $474 | $13 |
| Fenofibrate | 12 | $418 | $35 |
| Valsartan | 16 | $345 | $22 |
| Simvastatin | 37 | $312 | $8 |
| Bupropion Hcl Sr | 14 | $304 | $22 |
| Trazodone | 21 | $300 | $14 |
| Montelukast | 12 | $300 | $25 |
| Quetiapine | 16 | $296 | $18 |
| Venlafaxine Hcl Er | 21 | $288 | $14 |
| Allopurinol | 15 | $265 | $18 |
| Lovastatin | 28 | $236 | $8 |
| Fludrocortisone Acetate | 12 | $234 | $20 |
| Metoprolol | 26 | $219 | $8 |
| Amlodipine Besylate | 21 | $217 | $10 |
| Sertraline | 35 | $204 | $6 |
| Hydrochlorothiazide | 29 | $162 | $6 |
| Estradiol | 20 | $159 | $8 |
| Metformin | 16 | $149 | $9 |
| Atenolol | 20 | $149 | $7 |
| Omeprazole | 13 | $148 | $11 |
| Alprazolam | 16 | $130 | $8 |
| Lisinopril | 26 | $123 | $5 |
| Alendronate | 11 | $112 | $10 |
| Clonazepam | 14 | $92 | $7 |
| Dicyclomine | 11 | $83 | $8 |
2016: 45 drugs
| Savella | 13 | $3,362 | $259 |
| Levothyroxine | 137 | $2,800 | $20 |
| Premarin | 11 | $1,669 | $152 |
| Oxybutynin Chloride Er | 20 | $1,461 | $73 |
| Hydrocodone-Acetaminophen | 41 | $1,413 | $34 |
| Duloxetine | 14 | $1,299 | $93 |
| Progesterone | 11 | $1,107 | $101 |
| Atorvastatin | 45 | $926 | $21 |
| Sulfamethoxazole-Trimethoprim | 13 | $792 | $61 |
| Enalapril Maleate | 14 | $780 | $56 |
| Liothyronine | 51 | $713 | $14 |
| Zolpidem | 28 | $709 | $25 |
| Escitalopram | 20 | $698 | $35 |
| Synthroid | 11 | $604 | $55 |
| Bupropion Xl | 17 | $576 | $34 |
| Gabapentin | 32 | $506 | $16 |
| Valsartan | 21 | $477 | $23 |
| Fenofibrate | 11 | $455 | $41 |
| Montelukast | 15 | $421 | $28 |
| Simvastatin | 38 | $403 | $11 |
| Lorazepam | 34 | $378 | $11 |
| Omeprazole | 24 | $301 | $13 |
| Estradiol | 19 | $293 | $15 |
| Baclofen | 17 | $287 | $17 |
| Metoprolol | 36 | $287 | $8 |
| Amlodipine Besylate | 28 | $263 | $9 |
| Lovastatin | 27 | $247 | $9 |
| Hydrochlorothiazide | 42 | $237 | $6 |
| Alendronate | 19 | $230 | $12 |
| Venlafaxine Hcl Er | 15 | $225 | $15 |
| Fludrocortisone Acetate | 12 | $213 | $18 |
| Trazodone | 13 | $197 | $15 |
| Lisinopril | 29 | $151 | $5 |
| Quetiapine | 18 | $148 | $8 |
| Alprazolam | 24 | $145 | $6 |
| Metformin | 12 | $140 | $12 |
| Dicyclomine | 16 | $132 | $8 |
| Citalopram Hbr | 13 | $124 | $10 |
| Paroxetine | 13 | $117 | $9 |
| Atenolol | 17 | $96 | $6 |
| Prednisone | 20 | $92 | $5 |
| Meloxicam | 11 | $77 | $7 |
| Pioglitazone | 12 | $77 | $6 |
| Tramadol | 11 | $73 | $7 |
| Clonazepam | 13 | $62 | $5 |
2015: 51 drugs
| Savella | 12 | $2,734 | $228 |
| Levothyroxine | 132 | $2,633 | $20 |
| Premarin | 16 | $2,417 | $151 |
| Celecoxib | 12 | $2,197 | $183 |
| Duloxetine | 14 | $1,338 | $96 |
| Venlafaxine Hcl Er | 15 | $1,298 | $87 |
| Hydrocodone-Acetaminophen | 36 | $1,155 | $32 |
| Vivelle-Dot | 12 | $990 | $82 |
| Zolpidem | 38 | $964 | $25 |
| Fluoxetine | 12 | $964 | $80 |
| Oxybutynin Chloride Er | 13 | $875 | $67 |
| Amantadine | 14 | $860 | $61 |
| Synthroid | 21 | $851 | $41 |
| Escitalopram | 60 | $741 | $12 |
| Pioglitazone | 15 | $729 | $49 |
| Enalapril Maleate | 17 | $657 | $39 |
| Bupropion Xl | 18 | $631 | $35 |
| Atorvastatin | 41 | $571 | $14 |
| Fenofibrate | 12 | $500 | $42 |
| Simvastatin | 55 | $475 | $9 |
| Gabapentin | 45 | $456 | $10 |
| Liothyronine | 40 | $428 | $11 |
| Lorazepam | 38 | $419 | $11 |
| Valsartan | 14 | $335 | $24 |
| Fluticasone Propionate | 16 | $326 | $20 |
| Estradiol | 21 | $283 | $13 |
| Pantoprazole | 14 | $271 | $19 |
| Lovastatin | 21 | $256 | $12 |
| Propafenone | 12 | $239 | $20 |
| Fludrocortisone Acetate | 11 | $230 | $21 |
| Baclofen | 16 | $229 | $14 |
| Montelukast | 11 | $220 | $20 |
| Alendronate | 23 | $219 | $10 |
| Lisinopril | 34 | $198 | $6 |
| Hydrochlorothiazide | 40 | $193 | $5 |
| Citalopram Hbr | 17 | $162 | $10 |
| Metoprolol | 22 | $154 | $7 |
| Pravastatin | 11 | $140 | $13 |
| Bupropion Hcl Sr | 13 | $135 | $10 |
| Carisoprodol | 12 | $125 | $10 |
| Paroxetine | 21 | $115 | $5 |
| Quetiapine | 12 | $103 | $9 |
| Carvedilol | 20 | $102 | $5 |
| Omeprazole | 13 | $88 | $7 |
| Prednisone | 20 | $84 | $4 |
| Clonazepam | 13 | $70 | $5 |
| Amlodipine Besylate | 14 | $67 | $5 |
| Atenolol | 16 | $64 | $4 |
| Metformin | 11 | $49 | $4 |
| Alprazolam | 14 | $43 | $3 |
| Meloxicam | 12 | $42 | $3 |
2014: 37 drugs
| Duloxetine | 12 | $2,608 | $217 |
| Eszopiclone | 12 | $2,164 | $180 |
| Levothyroxine | 98 | $1,545 | $16 |
| Premarin | 12 | $1,467 | $122 |
| Amantadine | 17 | $893 | $53 |
| Synthroid | 20 | $823 | $41 |
| Oxybutynin Chloride Er | 16 | $614 | $38 |
| Gabapentin | 33 | $538 | $16 |
| Hydrocodone-Acetaminophen | 22 | $500 | $23 |
| Fenofibrate | 11 | $496 | $45 |
| Liothyronine | 34 | $471 | $14 |
| Atorvastatin | 27 | $467 | $17 |
| Pioglitazone | 11 | $445 | $40 |
| Escitalopram | 28 | $367 | $13 |
| Simvastatin | 30 | $274 | $9 |
| Pantoprazole | 15 | $236 | $16 |
| Lovastatin | 19 | $231 | $12 |
| Zolpidem | 26 | $210 | $8 |
| Spironolactone | 11 | $210 | $19 |
| Lisinopril | 31 | $206 | $7 |
| Carvedilol | 26 | $204 | $8 |
| Bupropion Hcl Sr | 11 | $176 | $16 |
| Omeprazole | 21 | $174 | $8 |
| Fluticasone Propionate | 13 | $169 | $13 |
| Carisoprodol | 15 | $167 | $11 |
| Alendronate | 17 | $164 | $10 |
| Pravastatin | 12 | $140 | $12 |
| Benazepril | 12 | $138 | $11 |
| Lorazepam | 18 | $136 | $8 |
| Armour Thyroid | 16 | $126 | $8 |
| Amlodipine Besylate | 18 | $125 | $7 |
| Citalopram Hbr | 21 | $115 | $5 |
| Metoprolol | 18 | $92 | $5 |
| Quetiapine | 11 | $73 | $7 |
| Meloxicam | 12 | $62 | $5 |
| Hydrochlorothiazide | 15 | $51 | $3 |
| Metformin | 13 | $41 | $3 |
2013: 30 drugs
| Lunesta | 11 | $2,723 | $248 |
| Vytorin | 12 | $1,957 | $163 |
| Trilipix | 11 | $1,848 | $168 |
| Pioglitazone | 12 | $1,596 | $133 |
| Valacyclovir | 11 | $1,455 | $132 |
| Escitalopram | 11 | $1,145 | $104 |
| Proair Hfa | 13 | $915 | $70 |
| Atorvastatin | 13 | $618 | $48 |
| Levothyroxine | 53 | $599 | $11 |
| Liothyronine | 23 | $487 | $21 |
| Hydrocodone-Acetaminophen | 11 | $410 | $37 |
| Amlodipine Besylate | 25 | $373 | $15 |
| Pantoprazole | 16 | $360 | $23 |
| Simvastatin | 26 | $345 | $13 |
| Zolpidem | 45 | $331 | $7 |
| Synthroid | 11 | $282 | $26 |
| Lisinopril | 39 | $266 | $7 |
| Lovastatin | 16 | $238 | $15 |
| Gabapentin | 21 | $232 | $11 |
| Citalopram Hbr | 27 | $211 | $8 |
| Omeprazole | 15 | $158 | $11 |
| Armour Thyroid | 16 | $145 | $9 |
| Carvedilol | 11 | $143 | $13 |
| Metoprolol | 24 | $133 | $6 |
| Carisoprodol | 11 | $117 | $11 |
| Metformin | 15 | $102 | $7 |
| Lorazepam | 15 | $98 | $7 |
| Allopurinol | 12 | $96 | $8 |
| Pravastatin | 11 | $95 | $9 |
| Alprazolam | 12 | $60 | $5 |
Money from drug and device companies
$206 in 2025
| 2025 | 2 | 4 | None | $206 |
| 2024 | 6 | 37 | None | $651 |
| 2023 | 5 | 28 | None | $462 |
| 2022 | 5 | 21 | None | $452 |
| 2021 | 4 | 15 | None | $281 |
| 2020 | 3 | 3 | None | $68 |
| 2019 | 1 | 2 | None | $33 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biosense Webster | Carto 3 | $147 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $59 | 3 payments
|
See all 4 published payments
| Biosense Webster | Meals · 2025-12-12 | Carto 3 | $147 |
| Exact Sciences | Meals · 2025-09-17 | The Cologuard Plus Collection Kit | $22 |
| Exact Sciences | Meals · 2025-06-18 | Cologuard Collection Kit | $17 |
| Exact Sciences | Meals · 2025-03-10 | Cologuard Collection Kit | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $651
| Abbvie | Vraylar | $424 | 23 payments
|
| Pfizer | Nurtec Odt | $77 | 5 payments
|
| GlaxoSmithKline | Arexvy | $62 | 2 payments
|
| Lilly USA | Mounjaro | $41 | 2 payments
|
| Mayne Pharma Commercial | None | $30 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $17 | 1 payment
|
2023: $462
| Abbvie | Vraylar | $317 | 17 payments
|
| Lilly USA | Mounjaro | $63 | 3 payments
|
| Pfizer | Comirnaty | $33 | 2 payments
|
| Mayne Pharma Commercial | None | $31 | 5 payments
|
| Bausch Health US | Aplenzin | $18 | 1 payment
|
2022: $452
| Abbvie | Vraylar | $256 | 11 payments
|
| Bausch Health US | Aplenzin | $98 | 5 payments
|
| TherapeuticsMD | Annovera | $42 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $36 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $20 | 1 payment
|
2021: $281
| Biohaven Pharmaceuticals | Nurtec Odt | $131 | 7 payments
|
| AbbVie | Ubrelvy | $75 | 4 payments
|
| TherapeuticsMD | Annovera | $53 | 3 payments
|
| Arbor Pharmaceuticals | Edarbi | $22 | 1 payment
|
2020: $68
| GlaxoSmithKline | Shingrix | $31 | 1 payment
|
| Arbor Pharmaceuticals | Otovel | $20 | 1 payment
|
| Allergan | Ubrelvy | $16 | 1 payment
|
2019: $33
| TherapeuticsMD | Imvexxy | $33 | 2 payments
|
Professional record
- NPI
- 1063608743
- Licence
- CA A112811California A112811: Current · expires 2027-12-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 555 Knowles Dr Ste 109, Los Gatos, CA, 95032
- NPI first listed
- 2007-09-17
- NPI last updated
- 2024-05-17
- NPI record certified
- 2024-05-17
This is when the NPI record was last certified, not a medical board exam.